Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus Switch for CMV Control in Kidney Transplant
NCT04936971Phase 4Withdrawn
- Start
- Sep 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in cytomegalovirus infection (CMV). Planned start Sep 2021; status: withdrawn.
02
Drugs
everolimus
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT04936971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04936971.